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SUMMARY. The ability of the ‘alkaline’ components of reflux to cause harm in vivo is still open to debate,
although these components have been shown in vitro to be capable of damaging the mucosa. The precipitation of
bile acids and lysolecithin that occurs at low pH values is the main reason for questioning in vivo mucosal damage.
This study was undertaken to determine the composition of gastric aspirates at dierent original pH values and the
degree of solubility of the alkaline components when pH modifications are artificially induced. The samples for
chemical analysis were collected from indwelling nasogastric tubes after surgical procedures that did not involve the
upper gastrointestinal tract. Bile acid and lysolecithin concentrations were assessed by means of dedicated methods.
Thirty-five samples were available for bile acid evaluation and 27 for lysolecithin evaluation. Bile acid and
lysolecithin assessments were repeated after pH adjustment at 2, 3.5, 5.5 and 7. For easier assessment of the results,
three ranges of the original pH were selected (pH < 2, 2 £ pH < 5, pH ‡ 5). For each pH range, results were
pooled together and compared with those in the other pH ranges. Bile acid concentrations were 113  48,
339  90 and 900  303 (mean  s.e.m. lmol/L), respectively, in the three groups selected on account of the
dierent original pH values. Dierences were significant (p < 0.001). Both taurine- and glycine-conjugated bile
acids were represented even at pH < 2. No major dierences were observed in bile acid concentration with the
artificially induced pH variations. Lysolecithin concentrations were 5.99  3.27, 30.80  8.43 and
108.37  22.17 (mean  SEM lg/ml), respectively, in the three groups selected on account of the dierent
original pH ranges. Dierences were significant (p < 0.001). No significant dierences in lysolecithin
concentration were detected with the artificially induced pH variations. In conclusion, both bile acids and
lysolecithin are naturally represented in the gastric environment even at very low pH values, although their
concentrations decrease on lowering of the naturally occurring pH. Given the concentration variability of bile acids
and lysolecithin, further studies are needed to assess the minimal concentration capable of mucosal damage in vivo.
INTRODUCTION
The pathogenetic role of acid reflux (HCl and pepsin)
in esophageal mucosal damage has been clarified by a
number of both clinical and experimental studies.1–3
In contrast, the harmful eects of the so-called
‘alkaline’ components of reflux and even their
capability of refluxing into the esophagus are still
questioned4,5 and the problem of duodenogastroeso-
phageal reflux (DGR) remains unsettled. Many
studies have examined DGR from an experimental
point of view. They have unequivocally shown that,
among all the components which potentially reflux
into the esophagus, bile acids, lysolecithin and trypsin
are capable of causing esophageal mucosal damage in
a variety of animals.6–8 However, their harmful
eects seem to be heavily conditioned by the envi-
ronmental pH. In vitro experimental studies have
shown that trypsin is inactivated at pH < 6.5 and
lysolecithin at pH < 4. Unconjugated, glycoconju-
gated and tauroconjugated bile acids are precipitated
and, therefore, inactivated at pH < 5, 4 and 2
respectively.
More recently, an in vitro study has compared the
pH dependency of the solubility of the commercially
available bile acids, which have been used in all the
above-mentioned animal models, with that of the bile
acids in natural human bile.9 This study seems to
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show that, in contrast to commercial bile acids,
natural bile acids are all precipitated and therefore
inactivated at pH < 4.9
Thus, as a preliminary step to improve the
understanding of the noxious eects of ‘alkaline’
reflux, the purpose of the present study was to assess
the composition of gastric aspirates at dierent
original pH and to evaluate in vitro the solubility
(as an indirect index of the harmful potential) of
dierent naturally occurring Ôalkaline’ components of
reflux as a function of pH.
MATERIALS AND METHODS
All reagents were of the highest purity available. HCl,
KOH, hemoglobin (bovine), pepsin (porcine stomach
mucosa), lysophosphatidylcholine (bovine liver), tri-
chloroacetic acid, methanol, chloroform, NaCl,
EDTA and conjugated bile acid standards were
purchased from Sigma-Aldrich (Milan, Italy), silica
gel H and molybdenum blue reagent from Alltech
(Milan, Italy), and high-performance liquid chroma-
tography (HPLC) reagents from Merck (Frankfurter,
Germany).
Natural components of reflux were obtained from
indwelling nasogastric tubes after surgical procedures
that did not involve the upper gastrointestinal tract.
Aspirates were collected in the morning from fasted
patients. A quantity of 20–30 ml was collected each
time and placed in non-transparent-walled containers
to avoid light interference. Aspirates were immedi-
ately processed. The original pH was measured using
a pH-meter (Orion, model 420A). Then, samples were
adjusted to pH 1, 2, 3.5, 5.5 or 7 by adding to the
original aspirate HCl or KOH. The amount of added
HCl or KOH (5 M) ranged between 5 and 50 ll.
After pH adjustment, all samples were centrifuged at
1000 r.p.m. for 5 min in order to separate the
precipitate which was present in all the samples,
and proper amounts of each sample at dierent pH
(the original pH included) were processed for the
assessment of each individual component.
For a clearer statistical assessment of the results,
three dierent ranges of the original pH were selected
(pH < 2, 2 £ pH < 5, pH ‡ 5) and the results
obtained in the evaluation of each ‘alkaline’ compo-
nent for each individual sample were pooled together
with those in the other samples with original pH in
the same range and compared with those in the other
pH ranges.
Bile acids
Samples for bile acid assessment were diluted 1:2 with
water and processed for HPLC. A liquid chromato-
graph (model 235c, Perkin Elmer, Florence, Italy)
was used. An Altex Ultrapore Beckman column,
4.6 mm · 25 cm, 5 lm particle size (Beckman
Instruments, Fullerton, CA, USA) was used. The
solvent system was methanol/0.01 M KH2PO4 75:25.
To each liter of this mixture, 4.2 ml of 5 N NaOH
were added. The pH was then adjusted to pH 5.35 by
addition of H3PO4. The solvent was filtered through a
0.45-lm nylon filter before use. The solvent flow rate
of 0.7 ml/min produced operating pressures of
13 800–15 180 kPa.
Lysolecithin
Lysophosphatidylcholine (LPC) was assayed accord-
ing to the method of Tsai et al.10 Before lipid
extraction, 2 mM EDTA and 5 mM CaCl2 were
added to the samples of gastric aspirates to inhibit
phospholipase A activity. Lipids were extracted from
samples (500 ll) with methanol–chloroform (1:2).
After evaporation under a stream of nitrogen, sam-
ples were redissolved in a small quantity (50–100 ll)
of methanol–chloroform (1:2) and spotted in dupli-
cate on a thin-layer chromatography (TLC) plate
(silica gel H, thickness 0.5 mm) along with a known
amount of a standard LPC dissolved in chloroform.
The chromatogram was developed in chloroform–
methanol–water (65:24:4, v/v) and, after the solvent
front had ascended 20 cm (about 90 min), the plate
was removed, air dried and sprayed with molyb-
denum blue reagent. Blue spots, indicating phospho-
lipids, were immediately visible. The spots were
quantified by densitometry (software QUANTISCAN
FOR WINDOWS). LPC concentrations were estimated
by comparing the areas of the samples with those of
the standards. All results were expressed in lg/ml.
RESULTS
Bile acids
Dierent amounts of bile acids were detected in all of
the 21 samples with original pH ‡ 2 and in eight out
of the 14 (57.2%) samples with original pH < 2. The
total concentration in the original samples was
closely dependent on their pH (Table 1), and dier-
ences between the three groups selected on account of
the original pH (pH < 2, 2 £ pH < 5, pH ‡ 5) were
significant. Both taurine- and glycine-conjugated bile
acids were represented in all the three groups, with a
predominance of the glycine conjugated even in the
Table 1. Bile acid concentration in the samples pooled together on
account of dierent ranges of their original pH
Total concentration (lmol/l)
Mean  s.e.m.
pH < 2 (n = 14) 113  48*
2 £ pH < 5 (n = 11) 336  90*
pH ‡ 5 (n = 10) 900  303*
* p < 0.001 (ANOVA test).
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samples with original pH < 2 (Fig. 1). With the
artificially induced progressive pH increase, no rele-
vant dierences in total bile acid concentration were
demonstrated for samples with original pH < 2
(Fig. 2). In the samples with original pH ranging
between 2 and 5, no major dierences either at
increased or at decreased pH were found (Fig. 2). In
the samples with original pH ‡ 5, a more complex
trend was observed. Stationary values (in comparison
with values at original pH) were detected at interme-
diate pHs with consistent increases both at extremely
high and low pH values, although no significant
dierences were reached (Fig. 2).
Lysolecithin
Lysolecithin in dierent amounts was detected in six
of the 12 samples with pH < 2, in five of the seven
samples with intermediate pH (‡2 and <5) and in all
eight samples with pH ‡ 5. The lysolecithin concent-
ration in the original samples was closely dependent
on pH, as shown by the dierent concentrations that
were found in the dierent ranges of original pH
(Table 2). If the threshold below which lysolecithin is
inactivated (pH 4) is considered, eight of the 18
samples with pH £ 4 contained no lysolecithin,
whereas dierent amounts of lysolecithin were shown
in all the nine samples with pH >4. Mean (s.e.m.,
lg/ml) lysolecithin concentration was 17.59 (7.58)
in the former group and 99.96 (20.54) in the latter
(p < 0.001, ANOVA test). With the artificially induced
pH changes, no significant dierences in lysolecithin
concentration were detected in any of the three
groups distinguished upon the basis of the original
pH, although a trend towards a slight increase was
observed in all the three groups at the upper values of
the pH scale (Fig. 3).
DISCUSSION
The main finding of this study is that variable
amounts of each alkaline component of reflux are
present even at pH values around 1.
Alkaline components have been shown both clin-
ically and experimentally6–8 to be harmful to the
esophageal mucosa. Clinical evidence is represented
by the very severe esophagitis that follows total
gastrectomy (suggesting complete anacidity) with
esophagoduodenal anastomosis or, more recently
noted, with esophagojejunal anastomosis without a
complete exclusion of the esophagus from ‘alkaline’
reflux.11,12 The frequent occurrence of esophagitis
was the main reason for abandoning these types of
reconstruction. Moreover, esophagitis has been
shown in another situation with complete anacidity,
i.e. in the presence of atrophic gastritis associated
with pernicious anemia.13
Fig. 1—Concentration of the dierent bile acids in the samples
pooled together at dierent original pH values. TCA, taurocolic
acid; GCA, glycocolic acid; TCDCA, taurochenodesossicholate
acid; TDCA, taurodesossicholate acid; GCDCA,
glycochenodesossicholate acid; GDCA, glycodesossicholate acid.
Fig. 2—Total bile acid concentration at dierent artificially
induced pH values.
Table 2. Lysolecithin concentration in the samples pooled together
on account of the dierent ranges of their original pH
Total concentration (lg/ml)
Mean  s.e.m.
pH < 2 (n = 12) 5.99  3.27*
2 £ pH < 5 (n = 7) 30.80  8.43*
pH ‡ 5 (n = 8) 108.37  22.17*
*p < 0.001 (ANOVA test).
Fig. 3—Lysolecithin concentration at dierent artificially induced
pH values.
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Glyco- and tauroconjugated bile acids have been
reported to be harmful to the esophageal mucosa at
acid pH (pH below 4 and even down to pH 2 for
tauro-conjugated).6 In contrast, deconjugated bile
acids are more damaging at higher pH levels (pH
between 5 and 8).6 Lysolecithin has also been shown
to cause mucosal damage when in an acidic
environment,14 whereas damage caused by trypsin
is relevant only in the absence of acid.15 Whereas for
bile acids the concentration threshold is established
at 1 mmol/l,16 for lysolecithin the minimal concen-
tration above which mucosal damage occurs is
unknown.
However, all these experimental studies have
utilized commercial products inmono- or two-product
mixtures. This, indeed, does not reproduce the
naturally occurring situation. A more realistic experi-
mental model should utilize gastric aspirates with
known composition because the dierent alkaline
and acid components of reflux seem to reciprocally
interact and synergistically enhance their eects on
the esophageal mucosa. This means that the minimal
noxious concentrations of bile acids and lysolecithin
may be much lower in vivo than in vitro. However, a
preliminary condition for the harmful potential of
each Ôalkaline’ component is its permanence in
solution. In this respect, our findings, which show
that bile acids and lysolecithin are still in solution
down to pH 1, seem important. These data appear
even more relevant in view of the previously reported
evidence of a nearly complete precipitation of the
naturally occurring bile acids in human bile at
pH < 4.9 Moreover, they suggest that bile acids
and lysolecithin may be important for mucosal
damage as they are both in solution and not
inactivated at low pH. Although it has not been
studied in the present paper, trypsin is completely
inactivated at low pH, exerts its proteolytic activity at
pH around 7, and is probably the main, if not the
only, damaging agent of reflux in achlorhydric
conditions, such as total gastrectomy and atrophic
gastritis associated with pernicious anemia.
Therefore, because this study has shown that
concentrations of bile acids and lysolecithin decrease
with lowering of pH and that variable concentrations
can be found also at very low pH, the principal
unresolved problem is whether at pH around 2 (usual
gastric environmental pH) their concentration is still
such as to be capable of mucosal damage. However,
although up to the present time values for minimal
noxious concentrations have been obtained with
commercial products in mono- or two-product mix-
tures, studies with gastric aspirates, as opposed to
commercial products, are needed. This because the
interaction occurring in vivo between the dierent
Ôalkaline’ and acid components enhances the harmful
potential of each of them. As yet, it is not known
what is the in vivo threshold concentration for each
component that is capable of damaging the mucosa
when reflux consists of a mixture of HCl, pepsin, bile
acids, trypsin and lysolecithin. The harmful potential
of the mixture depends upon the fact that each single
component interacts with the others and aects their
physicochemical properties, such as solubility, lipo-
philicity and detergent capability. Moreover, even
more complex interactions take place. In this respect,
pH again plays a major role. Luminal acidity is
essential to determine intracellular bile acid accumu-
lation, which in turn seems the main determinant for
bile acid cytotoxic capability.17
In addition to the persistence in solution at low pH
values of bile acids and lysolecithin, another finding
of the present study is the role of pH in determining
the concentration of each component. More specifi-
cally relevant in this respect is the original pH, i.e. the
pH at the time of aspiration of gastric content. Only
minor concentration changes are caused following
artificially induced pH variations. This finding
suggest that early stabilization of physicochemical
properties of the gastric content occurs, and that
these are not later modified to any great extent by pH
changes.
If we consider that all the Ôalkaline’ components
may be represented in the refluxate, and that both
their concentration (as shown in the present paper)
and capacity to cause damage (as previously exper-
imentally shown) depend upon the original pH, the
advantages of simultaneously detecting ‘alkaline’
reflux and acidity by means of simultaneous Bilitec-
and pH monitoring are patent.18
In conclusion, in addition to the well-known
finding that, for about 2.5 h during the 24-h day,
gastric pH is above 4, even in normal subjects, our
finding that the ‘alkaline’ components of reflux are
present in solution even at low pH values supports
the possibility of interaction of the alkaline compo-
nents with esophageal and gastric mucosa even in
primary refluxers.
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